Literature DB >> 29396068

Significance of fatigue in patients with migraine.

Jong-Geun Seo1, Sung-Pa Park2.   

Abstract

Fatigue is often stated as a headache trigger or migraine-specific symptom. We investigated predictors of fatigue and its impact on quality of life (QOL) in patients with migraine. Patients with migraine were recruited from a headache clinic and completed psychosomatic instruments, including the 12-item Allodynia Symptom Checklist (ASC-12), the Migraine Disability Assessment Scale (MIDAS), the Patients Health Questionnaire-9 (PHQ-9), the Generalized Anxiety Disorder-7 (GAD-7), the Epworth Sleepiness Scale (ESS), the Insomnia Severity Index (ISI), the Fatigue Severity Scale (FSS), and Migraine-Specific Quality of Life Questionnaire (MSQ). Two hundreds twenty-six patients with migraine were eligible for the study. Pathologic fatigue was manifested in 133 patients (58.8%). The FSS score was significantly associated with age, age of onset, the Visual Analog Scale (VAS) depicting headache intensity, photophobia, phonophobia, and the scores of the ASC-12, the MIDAS, the ESS, the ISI, the PHQ-9 and the GAD-7. The strongest predictor for the FSS was the PHQ-9 (β = 0.432, p < .001), followed by age (β = -0.169, p = .002), the ISI (β = 0.151, p = .016), and the VAS (β = 0.139, p = .018). There was an inverse correlation between the FSS score and three dimensional scores of the MSQ (p < .001). Appropriate interventions for depression, insomnia, and headache intensity are likely to lessen fatigue and improve QOL.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Depression; Fatigue; Headache intensity; Insomnia; Migraine; QOL

Mesh:

Year:  2018        PMID: 29396068     DOI: 10.1016/j.jocn.2018.01.032

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  7 in total

1.  Clinical significance of sensory hypersensitivities in migraine patients: does allodynia have a priority on it?

Authors:  Jong-Geun Seo; Sung-Pa Park
Journal:  Neurol Sci       Date:  2018-12-01       Impact factor: 3.307

2.  Clinical significance of osmophobia and its effect on quality of life in people with migraine.

Authors:  Emine Meşe Pekdemir; Nermin Tanik
Journal:  Acta Neurol Belg       Date:  2022-07-21       Impact factor: 2.471

3.  Effects of onabotulinumtoxinA treatment for chronic migraine on common comorbidities including depression and anxiety.

Authors:  Andrew M Blumenfeld; Stewart J Tepper; Lawrence D Robbins; Aubrey Manack Adams; Dawn C Buse; Amelia Orejudos; Stephen D Silberstein
Journal:  J Neurol Neurosurg Psychiatry       Date:  2019-01-10       Impact factor: 10.154

Review 4.  Cerebro-Cerebellar Networks in Migraine Symptoms and Headache.

Authors:  Rodrigo Noseda
Journal:  Front Pain Res (Lausanne)       Date:  2022-07-13

Review 5.  Migraine Is More Than Just Headache: Is the Link to Chronic Fatigue and Mood Disorders Simply Due to Shared Biological Systems?

Authors:  Nazia Karsan; Peter J Goadsby
Journal:  Front Hum Neurosci       Date:  2021-06-03       Impact factor: 3.169

6.  Aggression and its association with suicidality in migraine patients: a case-control study.

Authors:  Sung-Pa Park; Jong-Geun Seo
Journal:  J Headache Pain       Date:  2018-08-14       Impact factor: 7.277

Review 7.  Imaging the Premonitory Phase of Migraine.

Authors:  Nazia Karsan; Peter J Goadsby
Journal:  Front Neurol       Date:  2020-03-25       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.